Table 4.
Participants’ assessment of two key topics [patient-centered outcomes research/comparative effectiveness research (PCOR/CER) and genetics]: phase I
| Survey topics | Baseline (Qa) | Summative (Qb) | n | ||
|---|---|---|---|---|---|
| Questions | Mean (SD) | Questions | Mean (SD) | ||
| CER/PCOR | Q1a. I am familiar with PCOR and CER | Q1b. How much has your knowledge about PCOR and CER changed? | |||
| Group 1* | 5.6 (1.9) | 7.9 (1.1) | 16 | ||
| Group 2** | 9.4 (0.9) | 6.8 (2.1) | 17 | ||
| Genetics | |||||
| Q2a. I find it important to incorporate genetic information into CER | 8.1 (2.1) | Q2b. How much has your opinion on “the importance of incorporating genetic information into outcomes research” changed? | 8.4 (1.7) | 29 | |
| Q3a. I have a clear understanding of how genetic information may be incorporated in CER | 6.1 (1.8) | Q3b. How much has your understanding of “how genetic information may be incorporated in PCOR and CER” changed? | 8.2 (1.2) | 29 | |
| Q4a. I am interested in using genetic information in CER studies | 8.2 (1.6) | Q4b. How much has your interest in using genetic information in PCOR and CER studies changed? | 8.2 (1.7) | 29 | |
n number of responses, SD standard deviation
*Limited experience with PCOR/CER prior to participation in phase I
**High level of experience with PCOR/CER prior to participation in phase I